… the impact of inhaled corticosteroids on fracture risk. However, … [25,26] and also ocular
hypertension or open-angle glaucoma.… corticosteroids and inhaled bronchodilators were modelled …

… bronchodilator therapy in isolation which has been associated with increased morbidity [9].
As well as the risk … Treatments consist of inhaled bronchodilators and corticosteroids either as …

… on the basis of a direct increase in risk of AAC as a consequence of … inhaled or nebulized
bronchodilators used to treat asthma or other chronic upper airway diseases. Bronchodilators …

… However, higher doses carry an increased risk of adverse effects … to assess the effect of 4
doses of inhaled albuterol (400 IJ.g, 1 mg, … benefit and adverse effects by visual analog scales. …

… as measured by the Borg and visual analogue scales, changes in arterial … aminophylline to
nebulised bronchodilators and oral … the risk of side effects and the complexity of management. …

… We deemed the Sanchez 1992 trial to be at high risk of reporting bias as the authors only
reported outcome data for the nine out of 12 participants who had shown a previous response …

… When faced with bronchospasm, nebulised bronchodilators such as beta2-agonists are the
agents of choice. Another important aspect of beta2-agonists is their anti-inflammatory effect. …

… use of acetylcysteine, and all other bronchodilators was allowed. … We did not find relevant
differences in the Eurol-5D visual analogue … Inhaled corticosteroids and the risk of mortality and …

… of inhaled bronchodilators as first-line therapy for COPD, questions remain regarding specific
aspects of bronchodilator … and risks of triple therapy (the two classes of long-acting inhaled …

… of inhaled corticosteroids (ICSs) has been associated with increased risk of bone and ocular
… For patients receiving dual long-acting bronchodilator therapy who experience continued …